1-3 of 3
Kelly K. Sawczyn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M. A. Linger, Alisa B. Lee-Sherick, Deborah DeRyckere, Rebecca A. Cohen, Kristen M. Jacobsen, Amy McGranahan, Luis N. Brandão, Amanda Winges, Kelly K. Sawczyn, Xiayuan Liang, Amy K. Keating, Aik Choon Tan, H. Shelton Earp, Douglas K. Graham
Journal: Blood
Blood (2013) 122 (9): 1599–1609.
https://doi.org/10.1182/blood-2013-01-478156
Published: 2013
Includes: Supplemental data
Journal Articles

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia

Rachel M. A. Linger, Deborah DeRyckere, Luis Brandão, Kelly K. Sawczyn, Kristen M. Jacobsen, Xiayuan Liang, Amy K. Keating, Douglas K. Graham
Journal: Blood
Blood (2009) 114 (13): 2678–2687.
https://doi.org/10.1182/blood-2009-03-209247
Published: 2009
Includes: Supplemental data
Journal Articles

Synergistic Killing of E2A-PBX1 + B-ALL Cells by Chemotherapeutic Agents and MerTK Inhibition

Rachel M.A. Linger, Ph.D., Deborah DeRyckere, Ph.D., Luis Brandão, Ph.D., Kelly K. Sawczyn, M.D., Amy K. Keating, M.D., Douglas K. Graham, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2843.
https://doi.org/10.1182/blood.V112.11.2843.2843
Published: 2008